11 March 2021
If you are interested in sponsoring the 2021 BioCapital Europe Conference please contact email@example.com or call +44 0750 0797 372
Event Organised by
LSP is one of the largest European investment firms providing financing for life sciences and health care companies. LSP’s management has raised over €2 billion ($2.3 billion) and developed more than 120 companies since it started to invest in 1988. With offices in Amsterdam, Munich and Boston, LSP currently has the possibility to invest from four funds, each having a distinctive investment scope and a dedicated team: LSP 6 invests in private early- to late-stage drug development and medical technology companies; LSP HEF 2 focuses on private late-stage medical technology companies with a health and economic benefit; the LSP Dementia Fund invests in companies targeting neurodegenerative diseases; and LSP Public targets public healthcare companies. Among LSP’s signature deals are argenx, Crucell, KuDOS, Movetis, Neuravi, Okairos, Prosensa, Qiagen and Zealand Pharma. In addition, LSP is an active contributor to the life sciences industry through roles as founder and board member of the Oncode Institute, initiator of the Dutch Venture Initiative (DVI), as well as board member of European venture capital associations, technology transfer institutes and government bodies. For more information: www.lspvc.com.
LifeSci Advisors (www.lifesciadvisors.com) is the largest investor relations firm in the healthcare sector and provides life science companies tailored solutions to global investor access and communication. Our experienced team is made up of former healthcare equity sales professionals, investment bankers, portfolio managers – all with 15+ years of Wall Street experience – plus scientists, equity analysts and journalists. We leverage our domain expertise to secure quality, one-on-one time with investors for our clients. We understand our clients’ financial, R&D, regulatory, and commercial goals and challenges, and help them not only to win valuable face time with leading investors but also to communicate in ways that resonate with specialist healthcare investors. LifeSci is active in and has offices in multiple cities in the U.S, Europe, Israel and China.
Russell Reynolds Associates
Loyens & Loeff
Loyens & Loeff offers top-level legal and tax advice for international businesses, financial institutions and government bodies.
Our Investment Management practice is the largest to offer a full range of investment management services in the Benelux. Our practice is multidisciplinary and closely integrated with other related practice areas, such as Private Equity (focusing specifically on private equity transactions such as leveraged buyouts and venture capital transactions), Tax, Real Estate and Banking & Finance. Our Investment Management practice also works closely with our firm’s Pharmaceuticals & Life Sciences Team and Healthcare Team, offering our clients in-depth sector knowledge, which enables us to offer truly integrated services.
Thanks to our closely collaborating legal and tax practices and our extensive sector knowledge, we have built up a unique and very solid position in the market, which enables us to effectively structuring and supervising both domestic and international matters.
Coulter Partners is a board and senior level global executive search specialist focused exclusively on Life Sciences. We work closely with those at the cutting edge of innovation in the industry in order to understand their challenges. With an extensive global network and expertise gained over 25 years in the sector, we have become trusted advisers on leadership in the pharmaceuticals, biotechnology, medical devices, diagnostics, CRO and services sectors. We also work with the global investor community, hiring for their own teams as well as building the boards and executive leadership teams of their portfolios companies. The largest dedicated Life Science search boutique in North America and Europe, we work in a unique way. We share knowledge and connections across the globe, as one team with one goal. To bring clients the world’s best talent.
At Goodwin, we use law to achieve unprecedented results for our clients. Our 1,000 plus lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigations and world-class advisory services in the financial, life sciences, private equity, real estate, and technology industries. We partner with our clients to practice law with integrity, ingenuity, agility and ambition. Our integrated, full-service team with focused industry expertise helps clients find the strategic paths that foster growth and minimize risk across all phases of the corporate life cycle, and serve all legal needs of life sciences clients — corporate, partnering, regulatory, intellectual property and litigation. To learn more, visit us at [www.goodwinlaw.com](http://www.goodwinlaw.com) and follow us on Twitter at @goodwinlaw and on LinkedIn.
Kempen & Co is a Dutch merchant bank providing financial services in corporate finance, equity research, asset management and securities broking. Our clients include corporates, institutional investors, financial institutions, (semi)public institutions, foundations and high net-worth individuals. One of Kempen & Co’s niches of expertise is Life Sciences & Healthcare. Kempen & Co takes a leading role in the pan-European Life Sciences & Healthcare space and supports its clients with M&A, private/public capital raising and other financial advisory services.
Allen & Overy
Allen & Overy Amsterdam is known for its individual experts and their ability to join forces, across practice areas and borders, to get deals done and to find solutions in highly complex cases. We are universally recognised market leaders in corporate transactions, banking & capital markets, governance & regulatory and disputes. Our global span of 44 offices with over 5,500 people and 550 partners covers established and emerging economies in the West and East and contains a network of over 90 highly experienced lawyers in life sciences.
We offer full-service and dedicated support for companies in the life sciences sector covering investments, start-ups and (venture) financing, mergers & acquisitions, IPO’s, capital market transactions, funds, intellectual property (contentious and non-contentious), regulatory and dispute resolution. Our experts have in-depth knowledge, presence and focus in the Dutch market and work together cross practice on a day-to-day basis. We cover all relevant areas, including pharma, biotech, medical devices, connected health, and consumer healthcare. Our unique experience of working with all relevant parties in the sector, from leading pharmaceutical, generics, biotech and medtech companies, as well as investors, universities and financial institutions has enhanced our ability to identify and anticipate the latest trends in the life sciences sector. Legal and regulatory developments in the Life Sciences sector are the topic of our dedicated blog, the Life Sciences Hub, and our CRISPR microsite, focusing on CRISPR related topics.
As a global top 40 law practice, Eversheds Sutherland provides legal services to a global client base ranging from small and mid-sized businesses to the largest multinationals, acting for 72 of the Fortune 100, 61 of the FTSE 100 and 120 of the Fortune 200.
With more than 2,800 lawyers, Eversheds Sutherland operates in 67 offices in 34 jurisdictions across Africa, Asia, Europe, the Middle East and the United States. In addition, a network of more than 200 related law firms, including formalized alliances in Latin America, Asia Pacific and Africa, provide support around the globe.
Our (international) Life Sciences Group is a highly recommended, multi-disciplinary legal team with extensive experience of the issues faced by the different sectors of the pharmaceutical, biosciences and medical devices industries. Specialists across the Group have extensive experience of the issues faced by the international biomedical industry with patent specialists across the world providing cutting-edge advice to the life sciences sector. Our Life Sciences Group is highly integrated and are able to advise you in multiple jurisdictions.
Pedersen & Partners
Pedersen & Partners, founded in 2001 by Poul Pedersen, is an integrated international Executive Search firm with 54 wholly owned offices in 50 countries and over 400 consultants and support staff across Europe, the Middle East, Africa, Asia & the Americas. Our values Trust, Relationship and Professionalism apply to our interaction with clients as well as executives.
Pedersen & Partners combines strong on-the-ground presence, with strong international practice groups. Our international team of dedicated Executive Search consultants works across all industry Practice Groups as a single, integrated international team to ensure that each client receives individual and customised attention.
Our dedicated Practice Groups assemble teams of international industry experts who bring up-to-date market knowledge and a track record of successfully supporting senior appointments in Biotech, MedTech as well as HealthTech. At the BioCapital event 2020, Pedersen & Partners will be represented by Figaro den Hollander, Country Manager (member of the Private Equity Practice), Lydia van der Meulen, Head Life Sciences & Healthcare Practice and Jaap den Hartog, our Biotech expert.
In addition to our international search expertise for executive positions, Pedersen & Partners also has a dedicated Board Practice for Non-Executives. We understand the importance of complex board governance issues, and the key roles that Board composition and effectiveness play in the successful and sustainable development of companies. We are aware that the cornerstone of a sound decision-making process when selecting candidates is the alignment of the board members’ skill sets with the company’s strategy, ownership structure and culture, and with international best practices. We always take into consideration current global trends, such as digital transformation, cyber security and risk management, regulation and compliance, diversity and transparency, reputation and integrity, independence and dedication, and shareholder empowerment.
Pedersen & Partners is 100% owned by a diverse team of Partners, who all work full-time to serve our clients. Operating as an integrated firm with one single profit centre, provides us with the unique capability to work as one team across the global organisation; and put the best team forward with industry, functional and geographical expertise.